Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 7 Thyroid Nodule 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Stomach Neoplasms 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 NSCLC 1 Lung Neoplasms 1 Leiomyoma 1 Hepatitis B 1 Gastrointestinal Stromal Tumors 1 Gastritis, Atrophic 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Cancer Metastatic 1 Bile Duct Neoplasms 1 Adrenocortical Adenoma 1 Adenocarcinoma 1

Interventions

pembrolizumab 1 osimertinib 1 icotinib 1 dacomitinib 1 camrelizumab 1 Radiofrequency Ablation 1 Microphysiological Systems 1 Liquid Biopsy 1 Gefitinib 1 Erlotinib Hydrochloride 1 Bevacizumab 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × NSCLC × Radiofrequency Ablation × Clear all

NCT01105182 2010-04-16

FACPT

The First Affiliated Hospital of Guangzhou Medical University

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡